Pediatrix Medical Group, Inc. (NYSE:MD) Stock Has Average Price Target of $26.60 According to Brokerages

Key Points

• Analysts maintain a “Hold” consensus on Pediatrix Medical Group, with five hold ratings and one buy rating among six covering brokerages. The average 12-month price target is $26.60.
• Pediatrix shares opened at $27.23, near their 12-month high of $28.02, with a market capitalization of approximately $2.21 billion and a P/E ratio of 13.03.
• The company exceeded quarterly expectations, reporting $0.63 in EPS versus a $0.59 consensus estimate and $487.78 million in revenue, up 4.1% year over year. Institutional investors own 97.71% of outstanding shares.

Pediatrix Medical Group, Inc. (NYSE:MD - Get Free Report) has earned a consensus recommendation of "Hold" from the six brokerages that are presently covering the company, Marketbeat.com reports. Five equities research analysts have rated the stock with a hold recommendation and one has issued a buy recommendation on the company. The average 12-month target price among brokers that have issued a report on the stock in the last year is $26.60.

A number of research analysts recently issued reports on MD shares. UBS Group boosted their target price on shares of Pediatrix Medical Group from $25.00 to $28.00 and gave the company a "neutral" rating in a research report on Thursday, August 6th. Truist Financial increased their price target on Pediatrix Medical Group from $23.00 to $28.00 and gave the stock a "hold" rating in a research report on Tuesday, July 14th. Weiss Ratings upgraded Pediatrix Medical Group from a "hold (c+)" rating to a "buy (b-)" rating in a research note on Wednesday, September 9th. Deutsche Bank Aktiengesellschaft reiterated a "hold" rating and set a $25.00 price objective on shares of Pediatrix Medical Group in a research note on Wednesday, August 5th. Finally, Wall Street Zen raised Pediatrix Medical Group from a "buy" rating to a "strong-buy" rating in a report on Sunday, September 13th.

Pediatrix Medical Group Price Performance

Shares of NYSE:MD opened at $27.23 on Tuesday. Pediatrix Medical Group has a twelve month low of $16.47 and a twelve month high of $28.02. The company's 50 day moving average is $26.48 and its 200 day moving average is $24.76. The company has a current ratio of 1.32, a quick ratio of 1.32 and a debt-to-equity ratio of 0.45. The company has a market cap of $2.21 billion, a PE ratio of 13.03 and a beta of 0.61.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last announced its quarterly earnings data on Tuesday, August 4th. The company reported $0.63 EPS for the quarter, beating the consensus estimate of $0.59 by $0.04. The business had revenue of $487.78 million during the quarter, compared to analysts' expectations of $478.49 million. Pediatrix Medical Group had a net margin of 8.96% and a return on equity of 20.05%. The business's quarterly revenue was up 4.1% compared to the same quarter last year. During the same period in the previous year, the business posted $0.53 EPS. On average, sell-side analysts forecast that Pediatrix Medical Group will post 2.17 EPS for the current year.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of MD. Global Retirement Partners LLC purchased a new stake in Pediatrix Medical Group in the 2nd quarter worth approximately $33,000. Nykredit A S purchased a new position in shares of Pediatrix Medical Group during the 2nd quarter valued at approximately $35,000. Integrated Wealth Concepts LLC purchased a new position in shares of Pediatrix Medical Group during the 2nd quarter valued at approximately $53,000. Fortitude Family Office LLC lifted its stake in shares of Pediatrix Medical Group by 2,239.3% in the 3rd quarter. Fortitude Family Office LLC now owns 2,082 shares of the company's stock valued at $54,000 after purchasing an additional 1,993 shares during the period. Finally, Public Employees Retirement System of Ohio acquired a new position in shares of Pediatrix Medical Group in the 2nd quarter valued at $63,000. 97.71% of the stock is currently owned by hedge funds and other institutional investors.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc provides physician-led health care services to hospitals, health systems and patients across the United States. The company focuses on specialized care for women, infants and children, supporting patients in hospital-based and affiliated clinical settings.

Its services include neonatal and perinatal care, maternal-fetal medicine, pediatric cardiology and other pediatric subspecialties. Pediatrix physicians commonly practice in neonatal intensive care units, delivery rooms, pediatric emergency departments and other hospital departments, working with care teams to manage complex medical needs.

The company was founded in 1979 and operated for many years under the name MEDNAX, Inc It adopted the Pediatrix Medical Group name in 2023 as part of a broader effort to emphasize its pediatric, neonatal and maternal-fetal health care businesses.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.